BC11A_HUMAN - dbPTM
BC11A_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID BC11A_HUMAN
UniProt AC Q9H165
Protein Name B-cell lymphoma/leukemia 11A
Gene Name BCL11A
Organism Homo sapiens (Human).
Sequence Length 835
Subcellular Localization Cytoplasm . Nucleus . Associates with the nuclear body. Colocalizes with SUMO1 and SENP2 in nuclear speckles (By similarity)..
Isoform 2: Cytoplasm . Nucleus . Predominantly localized in the nucleus in nuclear paraspeckles.
Isoform 3: Cytoplas
Protein Description Transcription factor associated with the BAF SWI/SNF chromatin remodeling complex (By similarity). Repressor of fetal hemoglobin (HbF) level. [PubMed: 26375765 Involved in brain development]
Protein Sequence MSRRKQGKPQHLSKREFSPEPLEAILTDDEPDHGPLGAPEGDHDLLTCGQCQMNFPLGDILIFIEHKRKQCNGSLCLEKAVDKPPSPSPIEMKKASNPVEVGIQVTPEDDDCLSTSSRGICPKQEHIADKLLHWRGLSSPRSAHGALIPTPGMSAEYAPQGICKDEPSSYTCTTCKQPFTSAWFLLQHAQNTHGLRIYLESEHGSPLTPRVGIPSGLGAECPSQPPLHGIHIADNNPFNLLRIPGSVSREASGLAEGRFPPTPPLFSPPPRHHLDPHRIERLGAEEMALATHHPSAFDRVLRLNPMAMEPPAMDFSRRLRELAGNTSSPPLSPGRPSPMQRLLQPFQPGSKPPFLATPPLPPLQSAPPPSQPPVKSKSCEFCGKTFKFQSNLVVHRRSHTGEKPYKCNLCDHACTQASKLKRHMKTHMHKSSPMTVKSDDGLSTASSPEPGTSDLVGSASSALKSVVAKFKSENDPNLIPENGDEEEEEDDEEEEEEEEEEEEELTESERVDYGFGLSLEAARHHENSSRGAVVGVGDESRALPDVMQGMVLSSMQHFSEAFHQVLGEKHKRGHLAEAEGHRDTCDEDSVAGESDRIDDGTVNGRGCSPGESASGGLSKKLLLGSPSSLSPFSKRIKLEKEFDLPPAAMPNTENVYSQWLAGYAASRQLKDPFLSFGDSRQSPFASSSEHSSENGSLRFSTPPGELDGGISGRSGTGSGGSTPHISGPGPGRPSSKEGRRSDTCEYCGKVFKNCSNLTVHRRSHTGERPYKCELCNYACAQSSKLTRHMKTHGQVGKDVYKCEICKMPFSVYSTLEKHMKKWHSDRVLNNDIKTE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
74PhosphorylationKRKQCNGSLCLEKAV
CCCCCCCCEEHHHHC
11.2628111955
86PhosphorylationKAVDKPPSPSPIEMK
HHCCCCCCCCCCCCC
46.6823401153
88PhosphorylationVDKPPSPSPIEMKKA
CCCCCCCCCCCCCCC
42.7330266825
96PhosphorylationPIEMKKASNPVEVGI
CCCCCCCCCCEEEEE
51.0126074081
106PhosphorylationVEVGIQVTPEDDDCL
EEEEEEECCCCCCCC
12.4626074081
114PhosphorylationPEDDDCLSTSSRGIC
CCCCCCCCCCCCCCC
32.3530576142
115PhosphorylationEDDDCLSTSSRGICP
CCCCCCCCCCCCCCC
20.1330576142
116PhosphorylationDDDCLSTSSRGICPK
CCCCCCCCCCCCCCC
18.0530576142
117PhosphorylationDDCLSTSSRGICPKQ
CCCCCCCCCCCCCCC
34.3230576142
123SumoylationSSRGICPKQEHIADK
CCCCCCCCCHHHHHH
65.0028112733
123UbiquitinationSSRGICPKQEHIADK
CCCCCCCCCHHHHHH
65.00-
130UbiquitinationKQEHIADKLLHWRGL
CCHHHHHHHHHHCCC
43.8821890473
130 (in isoform 1)Ubiquitination-43.8821890473
130 (in isoform 2)Ubiquitination-43.8821890473
130 (in isoform 3)Ubiquitination-43.8821890473
138PhosphorylationLLHWRGLSSPRSAHG
HHHHCCCCCCCHHCC
40.9117081983
139PhosphorylationLHWRGLSSPRSAHGA
HHHCCCCCCCHHCCC
29.4024719451
142PhosphorylationRGLSSPRSAHGALIP
CCCCCCCHHCCCCCC
28.1828348404
150PhosphorylationAHGALIPTPGMSAEY
HCCCCCCCCCCCCCC
26.02-
164SumoylationYAPQGICKDEPSSYT
CCCCCCCCCCCCCCE
64.3128112733
168PhosphorylationGICKDEPSSYTCTTC
CCCCCCCCCCEECCC
33.6526552605
169PhosphorylationICKDEPSSYTCTTCK
CCCCCCCCCEECCCC
34.8726552605
170PhosphorylationCKDEPSSYTCTTCKQ
CCCCCCCCEECCCCC
15.3526552605
171PhosphorylationKDEPSSYTCTTCKQP
CCCCCCCEECCCCCC
12.8126552605
173PhosphorylationEPSSYTCTTCKQPFT
CCCCCEECCCCCCCC
27.6826552605
174PhosphorylationPSSYTCTTCKQPFTS
CCCCEECCCCCCCCC
21.6126552605
198PhosphorylationNTHGLRIYLESEHGS
HCCCEEEEEECCCCC
9.6630576142
201PhosphorylationGLRIYLESEHGSPLT
CEEEEEECCCCCCCC
32.0923927012
205PhosphorylationYLESEHGSPLTPRVG
EEECCCCCCCCCCCC
20.7423401153
205 (in isoform 3)Phosphorylation-20.74-
208PhosphorylationSEHGSPLTPRVGIPS
CCCCCCCCCCCCCCC
16.6628355574
208 (in isoform 3)Phosphorylation-16.66-
214 (in isoform 3)Phosphorylation-19.2023684312
262PhosphorylationAEGRFPPTPPLFSPP
CCCCCCCCCCCCCCC
37.4630301811
267PhosphorylationPPTPPLFSPPPRHHL
CCCCCCCCCCCCCCC
44.1526329039
271Asymmetric dimethylargininePLFSPPPRHHLDPHR
CCCCCCCCCCCCHHH
35.31-
271MethylationPLFSPPPRHHLDPHR
CCCCCCCCCCCCHHH
35.31-
326PhosphorylationLRELAGNTSSPPLSP
HHHHHCCCCCCCCCC
29.6630266825
327PhosphorylationRELAGNTSSPPLSPG
HHHHCCCCCCCCCCC
44.8623401153
328PhosphorylationELAGNTSSPPLSPGR
HHHCCCCCCCCCCCC
28.6223401153
332PhosphorylationNTSSPPLSPGRPSPM
CCCCCCCCCCCCCHH
30.9623401153
337PhosphorylationPLSPGRPSPMQRLLQ
CCCCCCCCHHHHHCC
31.4823927012
350PhosphorylationLQPFQPGSKPPFLAT
CCCCCCCCCCCCCCC
48.9828122231
357PhosphorylationSKPPFLATPPLPPLQ
CCCCCCCCCCCCCCC
27.8228122231
365PhosphorylationPPLPPLQSAPPPSQP
CCCCCCCCCCCCCCC
50.8828122231
376PhosphorylationPSQPPVKSKSCEFCG
CCCCCCCCCCCCCCC
29.9930631047
377UbiquitinationSQPPVKSKSCEFCGK
CCCCCCCCCCCCCCC
54.10-
378PhosphorylationQPPVKSKSCEFCGKT
CCCCCCCCCCCCCCE
26.4330631047
384AcetylationKSCEFCGKTFKFQSN
CCCCCCCCEEEEECC
52.55-
384UbiquitinationKSCEFCGKTFKFQSN
CCCCCCCCEEEEECC
52.55-
400PhosphorylationVVHRRSHTGEKPYKC
EEECCCCCCCCCCCC
48.5624719451
426PhosphorylationKLKRHMKTHMHKSSP
HHHHHHHHHCCCCCC
19.50-
431PhosphorylationMKTHMHKSSPMTVKS
HHHHCCCCCCCEEEC
25.6223312004
432PhosphorylationKTHMHKSSPMTVKSD
HHHCCCCCCCEEECC
24.4023312004
435PhosphorylationMHKSSPMTVKSDDGL
CCCCCCCEEECCCCC
28.3223312004
438PhosphorylationSSPMTVKSDDGLSTA
CCCCEEECCCCCCCC
36.2828450419
443PhosphorylationVKSDDGLSTASSPEP
EECCCCCCCCCCCCC
27.7028450419
444PhosphorylationKSDDGLSTASSPEPG
ECCCCCCCCCCCCCC
35.2828450419
446PhosphorylationDDGLSTASSPEPGTS
CCCCCCCCCCCCCCC
46.6522617229
447PhosphorylationDGLSTASSPEPGTSD
CCCCCCCCCCCCCCC
30.7122617229
452PhosphorylationASSPEPGTSDLVGSA
CCCCCCCCCCHHCCH
29.7728450419
453PhosphorylationSSPEPGTSDLVGSAS
CCCCCCCCCHHCCHH
34.5628450419
458PhosphorylationGTSDLVGSASSALKS
CCCCHHCCHHHHHHH
19.9426074081
460PhosphorylationSDLVGSASSALKSVV
CCHHCCHHHHHHHHH
20.1726074081
461PhosphorylationDLVGSASSALKSVVA
CHHCCHHHHHHHHHH
37.0226074081
471SumoylationKSVVAKFKSENDPNL
HHHHHHHHCCCCCCC
57.04-
518PhosphorylationVDYGFGLSLEAARHH
CCHHCCCCHHHHHHC
25.2524719451
528PhosphorylationAARHHENSSRGAVVG
HHHHCCCCCCCCEEE
20.5924247654
529PhosphorylationARHHENSSRGAVVGV
HHHCCCCCCCCEEEC
46.4430576142
540PhosphorylationVVGVGDESRALPDVM
EEECCCHHHCCHHHH
27.8230301811
584PhosphorylationEAEGHRDTCDEDSVA
HHCCCCCCCCCCCCC
23.0830576142
589PhosphorylationRDTCDEDSVAGESDR
CCCCCCCCCCCCCCC
16.3023401153
594PhosphorylationEDSVAGESDRIDDGT
CCCCCCCCCCCCCCC
31.1326471730
601PhosphorylationSDRIDDGTVNGRGCS
CCCCCCCCCCCCCCC
20.1426471730
608PhosphorylationTVNGRGCSPGESASG
CCCCCCCCCCCCCCC
38.4723401153
612PhosphorylationRGCSPGESASGGLSK
CCCCCCCCCCCCCCH
33.3830266825
614PhosphorylationCSPGESASGGLSKKL
CCCCCCCCCCCCHHH
42.5530266825
618PhosphorylationESASGGLSKKLLLGS
CCCCCCCCHHHHCCC
30.9023927012
619UbiquitinationSASGGLSKKLLLGSP
CCCCCCCHHHHCCCH
53.11-
620SumoylationASGGLSKKLLLGSPS
CCCCCCHHHHCCCHH
40.7828112733
620UbiquitinationASGGLSKKLLLGSPS
CCCCCCHHHHCCCHH
40.78-
625PhosphorylationSKKLLLGSPSSLSPF
CHHHHCCCHHHCCCH
22.9023401153
627PhosphorylationKLLLGSPSSLSPFSK
HHHCCCHHHCCCHHH
45.6823927012
628PhosphorylationLLLGSPSSLSPFSKR
HHCCCHHHCCCHHHH
35.9323927012
630PhosphorylationLGSPSSLSPFSKRIK
CCCHHHCCCHHHHCC
26.3323401153
633PhosphorylationPSSLSPFSKRIKLEK
HHHCCCHHHHCCHHH
25.1423401153
634UbiquitinationSSLSPFSKRIKLEKE
HHCCCHHHHCCHHHC
59.53-
670UbiquitinationYAASRQLKDPFLSFG
HHHHHCCCCCCCCCC
55.83-
675PhosphorylationQLKDPFLSFGDSRQS
CCCCCCCCCCCCCCC
27.8030301811
679PhosphorylationPFLSFGDSRQSPFAS
CCCCCCCCCCCCCCC
32.3827732954
696PhosphorylationEHSSENGSLRFSTPP
CCCCCCCCEEECCCC
28.14-
700PhosphorylationENGSLRFSTPPGELD
CCCCEEECCCCCCCC
33.3023401153
701PhosphorylationNGSLRFSTPPGELDG
CCCEEECCCCCCCCC
30.6923401153
711PhosphorylationGELDGGISGRSGTGS
CCCCCCCCCCCCCCC
31.2826074081
714PhosphorylationDGGISGRSGTGSGGS
CCCCCCCCCCCCCCC
44.2028450419
716PhosphorylationGISGRSGTGSGGSTP
CCCCCCCCCCCCCCC
29.4428450419
718PhosphorylationSGRSGTGSGGSTPHI
CCCCCCCCCCCCCCC
39.5623401153
721PhosphorylationSGTGSGGSTPHISGP
CCCCCCCCCCCCCCC
42.1423401153
722PhosphorylationGTGSGGSTPHISGPG
CCCCCCCCCCCCCCC
23.3530576142
726PhosphorylationGGSTPHISGPGPGRP
CCCCCCCCCCCCCCC
35.5823927012
734PhosphorylationGPGPGRPSSKEGRRS
CCCCCCCCCCCCCCC
53.3223927012
735PhosphorylationPGPGRPSSKEGRRSD
CCCCCCCCCCCCCCC
37.0930576142
736UbiquitinationGPGRPSSKEGRRSDT
CCCCCCCCCCCCCCC
69.40-
741PhosphorylationSSKEGRRSDTCEYCG
CCCCCCCCCCCHHHH
35.5930576142
741 (in isoform 2)Phosphorylation-35.59-
743PhosphorylationKEGRRSDTCEYCGKV
CCCCCCCCCHHHHHH
14.4228111955
743 (in isoform 2)Phosphorylation-14.4228348404
745 (in isoform 2)Phosphorylation-46.0528348404
746 (in isoform 2)Phosphorylation-14.5128348404
748 (in isoform 2)Phosphorylation-28.4124719451
749UbiquitinationDTCEYCGKVFKNCSN
CCCHHHHHHHHHCCC
40.72-
752UbiquitinationEYCGKVFKNCSNLTV
HHHHHHHHHCCCCEE
61.09-
755PhosphorylationGKVFKNCSNLTVHRR
HHHHHHCCCCEEECC
44.24-
763PhosphorylationNLTVHRRSHTGERPY
CCEEECCCCCCCCCE
25.9223882029
765PhosphorylationTVHRRSHTGERPYKC
EEECCCCCCCCCEEC
41.8228464451
771UbiquitinationHTGERPYKCELCNYA
CCCCCCEECEECCHH
24.74-
784UbiquitinationYACAQSSKLTRHMKT
HHHHCCHHHHHHHHH
60.16-
810PhosphorylationEICKMPFSVYSTLEK
EECCCCCHHHHHHHH
17.8021406692
812PhosphorylationCKMPFSVYSTLEKHM
CCCCCHHHHHHHHHH
8.5021406692
813PhosphorylationKMPFSVYSTLEKHMK
CCCCHHHHHHHHHHH
25.1021406692
814PhosphorylationMPFSVYSTLEKHMKK
CCCHHHHHHHHHHHH
22.6521406692
833SumoylationRVLNNDIKTE-----
HHHCCCCCCC-----
49.8428112733

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of BC11A_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of BC11A_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of BC11A_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CHD4_HUMANCHD4physical
16091750
MTA2_HUMANMTA2physical
16091750
MTA1_HUMANMTA1physical
16091750
HDAC1_HUMANHDAC1physical
16091750
MBD3_HUMANMBD3physical
16091750
SIR1_HUMANSIRT1physical
15639232
BC11A_HUMANBCL11Aphysical
16704730
A4_HUMANAPPphysical
21832049
YMEL1_HUMANYME1L1physical
21988832
CDCA3_HUMANCDCA3physical
21988832
COT2_HUMANNR2F2physical
23975195
NR2E1_HUMANNR2E1physical
23975195
NR2E3_HUMANNR2E3physical
23975195
COT1_HUMANNR2F1physical
23975195
NR2F6_HUMANNR2F6physical
23975195

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of BC11A_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-205; THR-208; SER-332;SER-625; SER-630 AND THR-701, AND MASS SPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-86; SER-205 AND SER-608,AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-608, AND MASSSPECTROMETRY.

TOP